Breadth of anti-merozoite antibody responses is associated with the genetic diversity of asymptomatic Plasmodium falciparum infections and protection against clinical malaria.
about
Immunoregulation in human malaria: the challenge of understanding asymptomatic infectionGammaherpesvirus Co-infection with Malaria Suppresses Anti-parasitic Humoral ImmunityAntibody Responses to Plasmodium falciparum and Plasmodium vivax and Prospective Risk of Plasmodium spp. Infection Postpartum.An analytical approach to reduce between-plate variation in multiplex assays that measure antibodies to Plasmodium falciparum antigensDynamics in multiplicity of Plasmodium falciparum infection among children with asymptomatic malaria in central Ghana.Epidemiology of malaria in a village in the Rufiji River Delta, Tanzania: declining transmission over 25 years revealed by different parasitological metrics.New antigens for a multicomponent blood-stage malaria vaccineThe effect of daily co-trimoxazole prophylaxis on natural development of antibody-mediated immunity against P. falciparum malaria infection in HIV-exposed uninfected Malawian childrenMultiple clinical episodes of Plasmodium falciparum malaria in a low transmission intensity setting: exposure versus immunity.Asymptomatic Multiclonal Plasmodium falciparum Infections Carried Through the Dry Season Predict Protection Against Subsequent Clinical Malaria.Dynamics and role of antibodies to Plasmodium falciparum merozoite antigens in children living in two settings with differing malaria transmission intensity.Plasmodium falciparum msp2 Genotypes and Multiplicity of Infections among Children under Five Years with Uncomplicated Malaria in Kibaha, TanzaniaTargets and Mechanisms Associated with Protection from Severe Plasmodium falciparum Malaria in Kenyan Children.Progress and prospects for blood-stage malaria vaccinesAntibody acquisition models: A new tool for serological surveillance of malaria transmission intensity.Antibody responses to Plasmodium falciparum and Plasmodium vivax blood-stage and sporozoite antigens in the postpartum period.Changes in Serological Immunology Measures in UK and Kenyan Adults Post-controlled Human Malaria Infection.Antibody responses to a novel Plasmodium falciparum merozoite surface protein vaccine correlate with protection against experimental malaria infection in Aotus monkeys.Cord blood IgG and the risk of severe Plasmodium falciparum malaria in the first year of life.Immunity to malaria in an era of declining malaria transmission.Dynamics of the Human Infectious Reservoir for Malaria Determined by Mosquito Feeding Assays and Ultrasensitive Malaria Diagnosis in Burkina Faso.Merozoite Surface Protein 1 from Plasmodium falciparum Is a Major Target of Opsonizing Antibodies in Individuals with Acquired Immunity against Malaria.Natural antibody responses to Plasmodium falciparum MSP3 and GLURP(R0) antigens are associated with low parasite densities in malaria patients living in the Central Region of Ghana.P. falciparum infection and maternofetal antibody transfer in malaria-endemic settings of varying transmission.cGAS-mediated control of blood-stage malaria promotes Plasmodium-specific germinal center responses.High Level of Specific Anti-Plasmodium Falciparum Merozoite IgG1 Antibodies in Rural Asymptomatic Individuals of Dienga, South-Eastern Gabon.Lactococcus lactis provides an efficient platform for production of disulfide-rich recombinant proteins from Plasmodium falciparum.
P2860
Q26775212-72677C9A-4A26-40B5-BAAE-F8425AF663BDQ27320062-B4C5AF80-C2B2-4810-960C-87FD4B129652Q33636850-31DB470E-38AB-440B-99FF-A11E2CC8D9D3Q33909630-0DAC7542-8C9A-4D3A-B707-554FE5D6F101Q33913006-D4708903-D4B8-4233-97CF-0B3426B34C9AQ34898273-270F697E-36CA-4F66-BCD8-5E9ECC4AF425Q35216634-7394E652-B67B-46D6-9A80-AAC3DDF099D9Q35217416-6772F792-B5A5-4FC2-9288-2E6B82A0FD6BQ35628510-58C2AEE9-F6AC-4629-AD25-2C1756CBA11CQ35965161-1F924AED-2EA8-48C0-8CF2-69679BCAD0E3Q36381444-37067E8D-0026-4694-93B6-2BDB2C087B89Q36386728-644C9881-E52E-4744-B480-6B6F5FB84155Q36728063-90AB383A-F6A5-4CE7-8812-C99DD736597DQ37025030-A333D6CA-D964-46AA-8CBB-4499E79D957FQ37175027-C1954DE6-4053-4A58-AEB1-49FCD6D59E6BQ37202370-F80A488F-3FCE-46CF-8321-B9C93A144132Q37334935-C83B51D0-74C5-4E22-B60B-43FACA185A91Q37452080-7ED6D18F-48DC-46FC-8591-CDC8078DC32EQ37631228-06A01653-6552-484A-B663-A50555D3AE7AQ38689264-3C80CC1C-280E-4082-BE4A-51BC8EFF2828Q39331193-0AF42650-01D8-4B0C-AE6D-256E300C5F80Q40055186-FF3D1729-C6D2-49EB-AF08-56F3022886B6Q40082177-45D6FD5B-E36C-45C3-9E49-760A293AB138Q42701669-1398000B-36FA-459F-8A9B-D0335F57C795Q48023186-582B13EB-BD70-421C-9E00-FD34F23523ABQ49220322-A8733297-C9DB-49F2-9DA7-4888E1F4A924Q52606714-F4E5F558-C752-4A3F-A90B-62FE8E737625
P2860
Breadth of anti-merozoite antibody responses is associated with the genetic diversity of asymptomatic Plasmodium falciparum infections and protection against clinical malaria.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Breadth of anti-merozoite anti ...... tion against clinical malaria.
@en
Breadth of anti-merozoite anti ...... tion against clinical malaria.
@nl
type
label
Breadth of anti-merozoite anti ...... tion against clinical malaria.
@en
Breadth of anti-merozoite anti ...... tion against clinical malaria.
@nl
prefLabel
Breadth of anti-merozoite anti ...... tion against clinical malaria.
@en
Breadth of anti-merozoite anti ...... tion against clinical malaria.
@nl
P2093
P2860
P50
P921
P356
P1476
Breadth of anti-merozoite anti ...... tion against clinical malaria.
@en
P2093
Faith H A Osier
Josea Rono
Leah Mhoja
P2860
P304
P356
10.1093/CID/CIT556
P407
P577
2013-08-27T00:00:00Z